Decision to Acquire and Cancel KRW 20 Billion of 4th Series Convertible Bonds via Early Redemption
- On May 18, 2026, the company acquired KRW 20 billion (face value) of its 4th series unregistered unsecured private convertible bonds through exercise of put option, and plans to cancel all acquired bonds.
- Acquisition cost including principal and interest is approximately KRW 21.05 billion, funded by internal cash, via over-the-counter purchase.
- The bonds were issued on January 18, 2023 (maturity January 18, 2028) with a conversion price of KRW 2,729 (adjusted on April 18, 2025). The cancellation reduces potential dilution risk.
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance
- Company: LabGenomics (084650)
- Submission: LabGenomics Co., Ltd.
- Receipt: 05-18-2026
- Under KRX KOSDAQ Market Division